NISHIKAWA KEISOKU Co., Ltd.
7500・Standard Market・Wholesale Trade
Business
NISHIKAWA KEISOKU Co., Ltd. is an engineering trading company founded in 1932, specializing in measurement, control, and scientific/chemical fields. It operates four business segments—Control & Information Equipment Systems (PA/FA), Measuring Instruments, Scientific & Chemical Instruments, and Industrial Equipment & Others—serving a wide range of industrial customers, from public infrastructure entities such as water and sewage, electric power, and gas utilities to sectors including semiconductors, chemicals, automobiles, food, and pharmaceuticals. A distinguishing feature of the company is that it goes beyond mere product sales to provide an integrated package of engineering, software development, instrumentation construction work, and maintenance services. As an authorized distributor of the Yokogawa Electric group and Agilent Technologies, it procures key products and delivers closely tailored services to customers through its nationwide network of sales offices. The company is listed on the Standard Market of the Tokyo Stock Exchange.
Business Model
The company purchases measurement and control equipment from the Yokogawa Electric group and Agilent Technologies and sells to customers, with a distributor function at its core, while adding engineering, software development, instrumentation construction work, and maintenance services to achieve higher value-added. Against net sales of ¥38,719 million, gross profit was ¥8,786 million (gross profit margin of approximately 22.7%). Selling, general and administrative expenses were kept to ¥5,028 million (13.0% of net sales), securing operating income of ¥3,757 million (operating margin of 9.7%). Funding is fully covered by equity capital and operating cash flow.
Company Strengths
Revenue grew from ¥30,473 million and operating profit from ¥1,916 million in FY2021 to revenue of ¥38,719 million and operating profit of ¥3,757 million in FY2025, achieving +27.1% revenue growth and +96.1% operating profit growth over 5 periods. Profit growth has particularly accelerated since FY2024, and the improvement in earnings structure is confirmed numerically.
The equity ratio at the end of FY2025 stood at 60.4%, significantly exceeding the target of 50% or above, and ROE reached 13.8%, achieving the target of 10% or above. Net assets totaled ¥20,480 million, and cash and cash equivalents amounted to ¥9,606 million, maintaining a robust financial base close to debt-free management.
The order backlog at the end of FY2025 stood at ¥28,272 million (up 21.5% year-on-year). By item, Industrial Equipment & Others expanded sharply by 67.1% year-on-year to ¥5,940 million, and Measuring Instruments surged 93.1% to ¥1,667 million. Total orders received also reached ¥43,831 million (up 15.1% year-on-year), indicating robust demand and functioning as a leading indicator supporting revenue in subsequent periods.
ENVALITH's Perspective
Performance Trend
Revenue grew for five consecutive fiscal years, from ¥30,473 million in FY2021 to ¥38,719 million in FY2025. For FY2026 (ending June 2026), the full-year forecast stands at ¥45,000 million (up 16.2% year on year), indicating accelerating growth. Cumulative revenue for the first three quarters reached ¥35,665 million (up 13.3% year on year), driven by steady performance in lifeline-related businesses as well as external factors such as increased semiconductor-related capital investment demand and large automotive-related projects. The operating margin for the cumulative first three quarters was 10.9%, slightly down from 11.7% in the same period of the previous year, reflecting the impact of an increase in SG&A expenses (up 9.8% year on year). The dividend forecast has also been revised upward to ¥350 (an increase from ¥320 in the previous fiscal year).
Growth Strategy
Expanding value-added capabilities as an engineering trading company through the four strategies of SE2025
Steadily capturing equipment renewal demand related to lifelines (water, gas, electricity) through the existing customer base, while strengthening expansion into growth fields such as semiconductors and automobiles. Net sales for the cumulative nine months of FY2026 (ending June 2026) increased 13.3% year on year, with the effects of growth business expansion reflected in the figures.
Adding solutions such as lab DX to Scientific & Chemical Instruments sales, shifting from simple equipment sales to high-value-added proposals. Cumulative nine-month sales of Scientific & Chemical Instruments for FY2026 (ending June 2026) rose a steady 6.0% year on year, with differentiation through added solutions continuing.
Strengthening proposal-based sales that combine DX, IoT, and AI technologies with measurement and control systems. Orders received for Control & Information Equipment Systems increased 18.1% year on year, and order backlog increased 26.3% year on year, suggesting significant growth, indicating that the appeal of value-added proposals is contributing to order acquisition.
Advancing the maintenance of financial soundness and enhancement of shareholder returns in parallel. Revised the full-year dividend forecast for FY2026 (ending June 2026) upward to ¥350 per share (an increase of ¥30 year on year). While maintaining a sound equity ratio of 57.4%, net assets expanded to ¥24,293 million, up 18.6% from the previous fiscal year-end, due to an increase in the market value of investment securities (mainly Yokogawa Electric Corporation shares).
Last updated: July 17, 2026

